4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-25-220847
Chief Executive Officer sold 25,797 shares at $9.77 ($252,037)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Barrow Robert · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-25 | Sale : show line 1 in the form 10b5-1 | −25,797 | $9.77 | $252,037 | 804,268 | D |
| Open-market sales · 25,797 sh · avg $9.77 · $252,037 | ||||||
Loading xslF345X05/ownership.xml…